Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Coleman

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Obstetrics and Gynecology|June 23, 2000
Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patientsV E Von Gruenigen, R L Coleman, A J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2020
The forefront of ovarian cancer therapy: update on PARP inhibitorsM R Mirza, R L Coleman, A González-Martín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2021
Corrigendum to 'The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148-1159]M R Mirza, R L Coleman, A González-Martín, et al.
Gynecologic Oncology|July 2, 1998
In vivo studies of adenovirus-based p53 gene therapy for ovarian cancerV E von Gruenigen, J T Santoso, R L Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 19, 2007
Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomyP T Ramirez, M Frumovitz, R Dos Reis, et al.
British Journal of Cancer|July 9, 2014
Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective studyC Tian, D J Sargent, T C Krivak, et al.
Journal of Clinical Monitoring|March 1, 1997
The implementation and acceptance of an intra-operative anesthesia information management systemR L Coleman, T Stanley, W C Gilbert, et al.
Gynecologic Oncology|July 1, 1993
DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastasesR L Coleman, J C Schink, D S Miller, et al.
Gynecologic Oncology|October 19, 2001
Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancerJ O Schorge, N M Mahoney, D S Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Allelic loss and microsatellite alterations of chromosome 3p14.2 are more frequent in recurrent cervical dysplasiasW M Lin, E A Michalopulos, N Dhurander, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Obstetrics and Gynecology|June 23, 2000
Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patientsV E Von Gruenigen, R L Coleman, A J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2020
The forefront of ovarian cancer therapy: update on PARP inhibitorsM R Mirza, R L Coleman, A González-Martín, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2021
Corrigendum to 'The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148-1159]M R Mirza, R L Coleman, A González-Martín, et al.
Gynecologic Oncology|July 2, 1998
In vivo studies of adenovirus-based p53 gene therapy for ovarian cancerV E von Gruenigen, J T Santoso, R L Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 19, 2007
Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomyP T Ramirez, M Frumovitz, R Dos Reis, et al.
British Journal of Cancer|July 9, 2014
Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective studyC Tian, D J Sargent, T C Krivak, et al.
Journal of Clinical Monitoring|March 1, 1997
The implementation and acceptance of an intra-operative anesthesia information management systemR L Coleman, T Stanley, W C Gilbert, et al.
Gynecologic Oncology|July 1, 1993
DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastasesR L Coleman, J C Schink, D S Miller, et al.
Gynecologic Oncology|October 19, 2001
Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancerJ O Schorge, N M Mahoney, D S Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Allelic loss and microsatellite alterations of chromosome 3p14.2 are more frequent in recurrent cervical dysplasiasW M Lin, E A Michalopulos, N Dhurander, et al.
Pageof 11